FDA Approves First Drug for Cold Agglutinin Disease FDA Approves First Drug for Cold Agglutinin Disease

Sutimlimab-jome is the first drug to have FDA approval for the treatment cold agglutinin disease, a rare autoimmune hemolytic anemia in which antibodies destroy red blood cells.FDA Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news